display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - triple negative
la/mBC - TNBC - L2 - all populationla/mBC - TNBC - L2 - PDL1 positive
atezolizumab based treatment
atezolizumab plus SoC IMpassion-132, ITT population IMpassion-132, PD-L1 positive population

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons